
Peptide Blend
KLOW 80mg
KLOW blend containing GHK-Cu, BPC-157, TB-500 and KPV, studied for skin and tissue research.
Multiple named components in one vial. Check each listing’s exact composition.
5 products

Peptide Blend
KLOW blend containing GHK-Cu, BPC-157, TB-500 and KPV, studied for skin and tissue research.

Peptide Blend
GLOW blend containing GHK-Cu, BPC-157 and TB-500, studied for skin and tissue research.

Peptide Blend
CJC No DAC + Ipamorelin blend studied for growth hormone and sleep research.

Peptide Blend
BPC-157 + TB-500 blend studied for tissue and tendon research.
Expected restock By October 29

Peptide Blend
CagriSema blend containing Cagrilintide and Semaglutide, studied for appetite and metabolism research.
View compound →
A premixed blend combines more than one named compound in a single vial. Its labelled total describes the combined amount, not that amount of every ingredient. For example, GLOW 70mg contains 50mg GHK-Cu, 10mg BPC-157 and 10mg TB-500. KLOW 80mg adds 10mg KPV to those components.
CJC No DAC + Ipamorelin 10mg contains 5mg of each component. The BPC-157 + TB-500 10mg and 20mg listings contain equal splits: 5mg + 5mg and 10mg + 10mg respectively. Other blends have their own listing details; do not infer a ratio from the combined amount or another product.
Some researchers prefer a premixed blend; others prefer single-compound vials for precision in component selection. A bundle is different again: it groups separate products, rather than mixing them into one vial. Review the product identity, included components and exact vial amount before choosing. All listings are for Research Use Only, not human or animal consumption.
All compounds listed are supplied for in vitro laboratory and educational research only. They are not listed on the Australian Register of Therapeutic Goods (ARTG) and are not for human or animal consumption.